Campbell & Co. Investment Adviser »

Akero Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.5M 30k 50.58
2023-06-30 $838k 18k 46.69

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Redmile Group
Boxer Capital
Alliancebernstein
Yiheng Capital
Geode Capital Management
Perceptive Advisors
Fred Alger Management
Rock Springs Capital Management

View all funds holding Akero Therapeutics